Professor Sara Rankin has a degree and PhD in Pharmacology from Kings College London. Following research training in the University of California and at Cancer Research UK she joined the National Heart and Lung Institute (NHLI) in 1995. Now a Professor in Leukocyte and Stem Cell Biology at Imperial College London, she is a fellow of the Society of Biology and a Wellcome Trust Senior Investigator. Her current research is in the new field of regenerative pharmacology, investigating how we can use drugs to stimulate bone marrow stem cells to repair the body. In addition she is part of a European consortium aimed at optimizing regeneration of de-cellularized trachea scaffolds in vivo and is Theme Lead for Biology and Therapeutics in the Centre for Blast Injury Studies at Imperial. She has published extensively and is regularly invited to present her work at both national and international scientific meetings. Prof Rankin is committed to public engagement activities and in this capacity she is the NHLI’s Lead for Outreach, runs stem cell workshops for pupils and teachers, regularly participates in public debates and is the lead scientist in an arts project, “Wasted”, currently on tour in the UK.